S55 - MS Basic Science
Event Time: | Thursday May 9, 2019 3:30 pm to 5:30 pm |
Topic(s): | MS and CNS Inflammatory Disease |
Director(s): | |
Description: | |
Completion Message: | |
CME Credits: | 2 |
Core Competencies: |
Start/End Time | Title | Faculty |
---|---|---|
5:10 PM - 5:30 PM | Q&A Panel with Authors | Faculty |
Speaker | Disclosure |
---|
Start Time | Pub. | Title | Presenter |
---|---|---|---|
3:30 PM | 001 | Vascular Disease Risk Factors (VDRF) in MS is Associated with Brain ATP Abnormalities: Dysmetabolism May Drive MS Disease Progression. |
Disclosure: Dr. Yadav has nothing to disclose.
|
3:30 PM | 002 | Bile Acid Metabolism is Altered in Multiple Sclerosis and Supplementation Leads to Amelioration of Neuroinflammation |
Disclosure: Dr. Bhargava has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sanofi-Genzyme. Dr. Bhargava has received research support from EMD-Serono, Amylyx pharmaceuticals.
|
3:30 PM | 003 | Metabolic interference protects against a mouse model of multiple sclerosis. |
Disclosure: Dr. Jordan has nothing to disclose.
|
3:30 PM | 004 | mTORc1 but not JNK Inhibition Augments Glucocorticosteroid Efficacy in Multiple Sclerosis |
Disclosure: Dr. Hoepner has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novartis and Biogen Idec. He also received speaker’s honoraria from Biogen, Novartis, Merk and Almirall. Dr. Hoepner has received research support from Novartis and Biogen Idec.
|
3:30 PM | 005 | Circular RNA of Blood Leukocytes Contribute To Proinflammatory Changes in Relapsing-Remitting Multiple Sclerosis |
Disclosure: Dr. Mycko has nothing to disclose.
|
3:30 PM | 006 | Assessing the Balance Between Effector and Regulatory T cell Subsets in Pediatric Multiple Sclerosis |
Disclosure: Dr. Mexhitaj has nothing to disclose.
|
3:30 PM | 007 | Abnormal Frequency and Function of MR1-defined MAIT cells in Pediatric Multiple Sclerosis |
Disclosure: Dr. Mexhitaj has nothing to disclose.
|
3:30 PM | 008 | Human induced pluripotent Stem Cell-derived Astrocytes are differentially activated by Multiple Sclerosis-associated Cytokines |
Disclosure: Dr. Perriot has nothing to disclose.
|
3:30 PM | 009 | Oligodendrogenesis following cortical demyelination generates a novel myelination pattern |
Disclosure: Dr. Orthmann Murphy has nothing to disclose.
|
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
7:00 AM-9:00 AM |
---|
C7 -
Clinical Pearls in Autoimmune Neurology: Real World Cases
Stacey Clardy MD, PhD |
9:30 AM-11:30 AM |
C19 -
Multiple Sclerosis Overview I: Clinical Pearls
Mary Willis MD, FAAN |
1:30 PM-3:30 PM |
C29 -
Multiple Sclerosis Overview II: Clinical Advances
Scott Newsome DO, FAAN |
7:00 AM-9:00 AM |
---|
C44 -
Multiple Sclerosis Therapy: Symptom Management
Andrew Solomon MD, FAAN |
9:15 AM-12:00 PM |
Presidential Plenary Session
Natalia Rost MD, MPH, FAAN, FAHA |
11:30 AM-6:30 PM |
P1 -
Poster Session 1
|
1:00 PM-3:00 PM |
C49 -
Neurology Update I: Multiple Sclerosis, Sleep, and Neuromuscular Disease
Adam Quick MD, Ralph Jozefowicz MD, FAAN |
C56 -
Multiple Sclerosis Therapy: Disease-modifying Treatment I
Scott Newsome DO, FAAN |
S6 -
MS and CNS Inflammatory Disease: Clinical Considerations I
|
3:30 PM-5:30 PM |
C73 -
Multiple Sclerosis Therapy: Disease-modifying Treatment II
John Rose MD, FAAN |
7:00 AM-9:00 AM |
---|
C86 -
Neuromyelitis Optica Spectrum Disorders
Dean Wingerchuk MD, FAAN |
9:15 AM-12:00 PM |
Contemporary Clinical Issues Plenary Session
Randolph Marshall MD, FAAN |
11:30 AM-6:30 PM |
P2 -
Poster Session 2
|
1:00 PM-3:00 PM |
C100 -
Esclerosis Múltiple y Otras Enfermedades Inflamatorias Desmielinizantes y Autoinmunes del Sistema Nervioso Central (MS and Other Demyelinating Inflammatory and Autoimmune Central Nervous System Disorders)
Lilyana Amezcua MD, FAAN |
S12 -
Progressive Multiple Sclerosis
|
3:30 PM-5:30 PM |
S19 -
Child Neurology: Updates in Autism, Migraine, MS, and Stroke
|
7:00 AM-9:00 AM |
---|
C130 -
Diagnostic Pearls in Myelitis: a Case-based Approach
Eoin Flanagan MBBCh |
9:15 AM-11:30 AM |
Clinical Trials Plenary Session
Deborah Hall MD, PhD, FAAN, Holly Hinson MD, MCR, FAAN |
11:30 AM-6:30 PM |
P3 -
Poster Session 3
|
1:00 PM-3:00 PM |
C142 -
Autoimmune Neurology I Basics and Beyond: Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes of the CNS and PNS
Stacey Clardy MD, PhD |
N3 -
Neuroscience in the Clinic: Stem Cells
Antonio Omuro MD, Paul George MD, PhD, MSE |
S26 -
MS and CNS Inflammatory Disease: Clinical Considerations II
|
3:30 PM-5:30 PM |
C160 -
Autoimmune Neurology II Advanced: Autoimmune Encephalitis at the Frontiers of Neuroscience
Eoin Flanagan MBBCh |
S31 -
MS and CNS Inflammatory Disease: Imaging
|
9:15 AM-11:30 AM |
---|
Frontiers in Neuroscience Plenary Session
Paul George MD, PhD, MSE |
11:30 AM-6:30 PM |
P4 -
Poster Session 4
|
1:00 PM-3:00 PM |
C181 -
Treatment of Pediatric Multiple Sclerosis in the Current Era
Brenda Banwell MD, FAAN |
S37 -
MS Biomarkers
|
3:30 PM-5:30 PM |
Presentation of the John Dystel Prize for Multiple Sclerosis Research
|
3:45 PM-4:15 PM |
Update on the Complementary Therapies for MS: An Evidence-based Review
Vijayshree Yadav MD, FAAN |
11:30 AM-6:30 PM |
---|
P5 -
Poster Session 5
|
12:00 PM-12:45 PM |
A "How to and Why" of the Shared Medical Appointments: A Way to Meet the Needs of the Patient and Provider While Maximizing Clinical Time
Nancy Isenberg MD, MPH, FAAN, Mary Rensel MD, FAAN |
1:00 PM-3:00 PM |
C226 -
Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I
Jeffrey Gelfand MD, MAS, FAAN |
S49 -
MS Epidemiology and Risk Stratification
|
3:30 PM-5:30 PM |
C236 -
Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II
Jeffrey Gelfand MD, MAS, FAAN |
7:00 AM-9:00 AM |
---|
C248 -
Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making
Aaron Miller MD, FAAN |
9:15 AM-11:30 AM |
Neurology Year in Review Plenary Session
Martinson Arnan MD |
1:00 PM-3:00 PM |
S56 -
MS Trials and Treatment
|
3:30 PM-4:30 PM |
C257 -
Education Blitz: Evolution of Autoimmune Neurology
Steven Vernino MD, PhD, FAAN |
C258 -
Education Blitz: Multiple Sclerosis
Stephen Krieger MD, FAAN |